Sodium nitrite/sodium thiosulfate
 | This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these template messages)
|
| Combination of | |
|---|---|
| Sodium nitrite (medical use) | Antidote |
| Sodium thiosulfate (medical use) | Antidote |
| Clinical data | |
| Trade names | Nithiodote |
| AHFS/Drugs.com | Professional Drug Facts |
| License data | |
| Routes of administration | Intravenous |
| ATC code |
|
| Legal status | |
| Legal status | |
| Identifiers | |
| PubChem CID | |
| UNII | |
Sodium nitrite/sodium thiosulfate, sold under the brand name Nithiodote, is a fixed-dose combination medication used as an antidote for cyanide poisoning.[1] It contains sodium thiosulfate and sodium nitrite.[1] It is given by intravenous infusion into a vein.[1]
It was approved for medical use in the United States in January 2011.[2]
Medical uses[edit]
Sodium nitrite/sodium thiosulfate is indicated for the treatment of acute cyanide poisoning.[1]
See also[edit]
References[edit]
- ^ a b c d e "Nithiodote- sodium nitrite and sodium thiosulfate kit". DailyMed. Retrieved 17 January 2021.
- ^ "Drug Approval Package: Nithiodote (sodium nitrite and sodium thiosulfate) NDA #201444". U.S. Food and Drug Administration (FDA). 10 February 2012. Retrieved 17 January 2021.
Rappaport BA (14 January 2011). "Application Number: 201444Orig1s000" (PDF) (Summary Review). Center for Drug Evaluation and Research.
External links[edit]
- "Sodium nitrite mixture with sodium thiosulfate". Drug Information Portal. U.S. National Library of Medicine.
 | This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |